Oncotarget New Tool Uses NF-κB Activity to Classify HPV+ Head and Neck Cancer Researchers developed a new tool aimed at better classifying HPV+ HNSCC patients with good or... read more May 26, 2022
Oncotarget Trending With Impact: Dual Requirement in Stem Cell Leukemia/Lymphoma For the first time, researchers revealed the protein interactome, phospho-proteome and total proteome for the... read more May 12, 2022
Oncotarget Gene Variants Investigated in Polish Bladder and Kidney Cancer Two gene variants were studied in large-scale cohorts for their potential roles in bladder and... read more April 27, 2022
Oncotarget Trending With Impact: Analysis of Mutational Burden in NSCLC Researchers conducted a multi-site cohort study of tumor mutational burden among hundreds of patients diagnosed... read more April 21, 2022
Oncotarget Trending With Impact: Genes Identified in Endocrine Therapy Resistance Researchers studied the dynamic behavior of gene expression during the development of endocrine therapy resistance... read more April 14, 2022
Oncotarget Novel Therapeutic Strategies Against Endometrial Cancer In a new study, researchers investigated the role of the (pro)renin receptor in endometrial... read more April 6, 2022
Oncotarget Compound in Cruciferous Vegetables Inhibits Cancer Cells The mechanism(s) by which a nutrigenetic compound exerts its therapeutic effect on bronchial carcinoid... read more March 31, 2022
Oncotarget Trending With Impact: Interrelated Oncogenic Pathways in Osteosarcoma Researchers evaluated the roles and relationship between two cancer-related signaling pathways in osteosarcoma.The Trending... read more March 24, 2022
Oncotarget Trending With Impact: Adjunct Virotherapy Fights Multiple Myeloma Researchers investigated using oncolytic viruses to treat multiple myeloma—alone and in a combination approach.... read more March 17, 2022
Oncotarget A Remote Weight Loss Strategy for Breast Cancer Survivors Researchers Jennifer Y. Sheng and Vered Stearns discussed the results of a study that compared... read more March 9, 2022